Authors:
Muehlenweg, B
Sperl, S
Magdolen, V
Schmitt, M
Harbeck, N
Citation: B. Muehlenweg et al., Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours, EXPERT OP B, 1(4), 2001, pp. 683-691
Authors:
Magdolen, V
Burgle, M
de Prada, NA
Schmiedeberg, N
Riemer, C
Schroeck, F
Kellermann, J
Degitz, K
Wilhelm, OG
Schmitt, M
Kessler, H
Citation: V. Magdolen et al., Cyclo(19,31)[D-Cys(19)]-uPA(19-31) is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87), BIOL CHEM, 382(8), 2001, pp. 1197-1205
Authors:
Lutz, V
Reuning, U
Kruger, A
Luther, T
von Steinburg, SP
Graeff, H
Schmitt, M
Wilhelm, OG
Magdolen, V
Citation: V. Lutz et al., High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nudemice, BIOL CHEM, 382(5), 2001, pp. 789-798
Authors:
Schwab, W
Gavlik, JM
Beichler, T
Funk, RHW
Albrecht, S
Magdolen, V
Luther, T
Kasper, M
Shakibaei, M
Citation: W. Schwab et al., Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and beta(1)-integrin, HISTOCHEM C, 115(4), 2001, pp. 317-323
Citation: E. Braungart et al., Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes, J INVES DER, 116(5), 2001, pp. 778-784
Authors:
Kruger, A
Soeltl, R
Sopov, I
Kopitz, C
Arlt, M
Magdolen, V
Harbeck, N
Gansbacher, B
Schmitt, M
Citation: A. Kruger et al., Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis, CANCER RES, 61(4), 2001, pp. 1272-1275
Authors:
Sperl, S
Bergner, A
Sturzebecher, J
Magdolen, V
Bode, W
Moroder, L
Citation: S. Sperl et al., Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies, BIOL CHEM, 381(4), 2000, pp. 321-329
Authors:
Schmitt, M
Wilhelm, OG
Reuning, U
Kruger, A
Harbeck, N
Lengyel, E
Graeff, H
Gansbacher, B
Kessler, H
Burgle, M
Sturzebecher, J
Sperl, S
Magdolen, V
Citation: M. Schmitt et al., The urokinase plasminogen activator system as a novel target for tumour therapy, FIBRINOL PR, 14(2-3), 2000, pp. 114-132
Authors:
Kotzsch, M
Luther, T
Harbeck, N
Ockert, D
Lutz, V
Noack, E
Grossmann, D
Albrecht, S
Kramer, MD
Lossnitzer, A
Grosser, M
Schmitt, M
Magdolen, V
Citation: M. Kotzsch et al., New ELISA for quantitation of human urokinase receptor (CD87) in cancer, INT J ONCOL, 17(4), 2000, pp. 827-834
Authors:
Kruger, A
Soeltl, R
Lutz, V
Wilhelm, OG
Magdolen, V
Rojo, EE
Hantzopoulos, PA
Graeff, H
Gansbacher, B
Schmitt, M
Citation: A. Kruger et al., Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87), CANC GENE T, 7(2), 2000, pp. 292-299
Authors:
Hildenbrand, R
Leitz, M
Magdolen, V
Luther, T
Albrecht, S
Graeff, H
Stutte, HJ
Bleyl, U
Schmitt, M
Citation: R. Hildenbrand et al., Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization, HISTOPATHOL, 36(6), 2000, pp. 499-504
Authors:
Beschorner, R
Schluesener, HJ
Nguyen, TD
Magdolen, V
Luther, T
Pedal, I
Mattern, R
Meyermann, R
Schwab, JM
Citation: R. Beschorner et al., Lesion-associated accumulation of uPAR/CD87-expressing infiltrating granulocytes, activated microglial cells/macrophages and upregulation by endothelial cells following TBI and FCI in humans, NEUROP AP N, 26(6), 2000, pp. 522-527
Authors:
Fauser, S
Deininger, MH
Kremsner, PG
Magdolen, V
Luther, T
Meyermann, R
Schluesener, HJ
Citation: S. Fauser et al., Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria, J NEUROIMM, 111(1-2), 2000, pp. 234-240
Authors:
Muehlenweg, B
Guthaus, E
de Prada, NA
Schmitt, M
Schmiedeberg, N
Kotzsch, M
Creutzburg, S
Kramer, MD
Kessler, H
Wilhelm, OG
Magdolen, V
Citation: B. Muehlenweg et al., Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptides, THROMB RES, 98(1), 2000, pp. 73-81
Authors:
Sperl, S
Jacob, U
de Prada, NA
Sturzebecher, J
Wilhelm, OG
Bode, W
Magdolen, V
Huber, R
Moroder, L
Citation: S. Sperl et al., (4-Aminomethyl)phenylguanidine derivatives as nonpeptidic highly selectiveinhibitors of human urokinase, P NAS US, 97(10), 2000, pp. 5113-5118
Authors:
Helfrich, W
Haisma, HJ
Magdolen, V
Luther, T
Bom, VJJ
Westra, J
van der Hoeven, R
Kroesen, BJ
Molema, G
de Leij, L
Citation: W. Helfrich et al., A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions, J IMMUNOL M, 237(1-2), 2000, pp. 131-145
Authors:
Muehlenweg, B
Assfalg-Machleidt, I
Parrado, SG
Burgle, M
Creutzburg, S
Schmitt, M
Auerswald, EA
Machleidt, W
Magdolen, V
Citation: B. Muehlenweg et al., A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction - Cystatin with a urokinase receptor binding site, J BIOL CHEM, 275(43), 2000, pp. 33562-33566
Authors:
Noack, F
Helmecke, D
Rosenberg, R
Thorban, S
Nekarda, H
Fink, U
Lewald, J
Stich, M
Schutze, K
Harbeck, N
Magdolen, V
Graeff, H
Schmitt, M
Citation: F. Noack et al., CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopy, INT J ONCOL, 15(4), 1999, pp. 617-623
Authors:
Wilhelm, OG
Wilhelm, S
Escott, GM
Lutz, V
Magdolen, V
Schmitt, M
Rifkin, DB
Wilson, EL
Graeff, H
Brunner, G
Citation: Og. Wilhelm et al., Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression, J CELL PHYS, 180(2), 1999, pp. 225-235
Authors:
Muller, M
Albrecht, S
Golfert, F
Hofer, A
Funk, RHW
Magdolen, V
Flossel, C
Luther, T
Citation: M. Muller et al., Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells, EXP CELL RE, 248(1), 1999, pp. 136-147
Authors:
Reuning, U
Guerrini, L
Nishiguchi, T
Page, S
Seibold, H
Magdolen, V
Graeff, H
Schmitt, M
Citation: U. Reuning et al., Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells, EUR J BIOCH, 259(1-2), 1999, pp. 143-148